MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, XXII had $2,727K increase in cash & cash equivalents over the period. -$7,784K in free cash flow.

Cash Flow Overview

Change in Cash
$2,727K
Free Cash flow
-$7,784K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Net proceeds from series a conve...
    • Net proceeds from warrant exerci...
    • Contract liabilities
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Payments of long-term debt
    • Accounts payable
    • Others

Cash Flow
2025-12-31
Net loss
-5,054
Impairment of long-lived assets - held for sale
293
Impairment of long-lived assets
150
Amortization and depreciation
912
Amortization of right-of-use assets
245
Other non-cash gains
32
Provision for credit losses
388
(gain) loss on sale or disposal of property, plant, and equipment
12
Debt related charges included in interest expense
1,586
Equity-based compensation
421
Change in fair value of warrant liabilities
207
Deferred income taxes
7
Change in inventory reserves
-261
Accounts receivable
1,883
Inventories
2,050
Prepaid expenses and other assets
1,350
Accounts payable
-2,656
Accrued expenses and other current liabilities
-253
Accrued excise taxes and fees
1,305
Contract liabilities
1,701
Other liabilities
-1,387
Net cash used in operating activities
-7,723
Acquisition of patents, trademarks, and licenses
814
Acquisition of property, plant and equipment
61
Proceeds from the sale of property, plant and equipment
770
Issuance of 2025 gvb promissory note
500
Payments received from 2025 gvb promissory note
100
Net cash used in investing activities
-505
Payments on notes payable
1,202
Proceeds from issuance of notes payable
1,655
Payments of penalties from long-term debt
28
Payments of long-term debt
4,308
Net proceeds from warrant exercise
5,075
Net proceeds from series a convertible preferred stock
9,893
Payments of deferred offering costs
130
Net cash provided by financing activities
10,955
Net increase in cash and cash equivalents
2,727
Cash and cash equivalents - beginning of year
4,422
Cash and cash equivalents - end of year
7,149
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net proceeds fromseries a convertible...$9,893K Net proceeds fromwarrant exercise$5,075K Proceeds from issuance ofnotes payable$1,655K Net cash provided byfinancing activities$10,955K Canceled cashflow$5,668K Net increase in cashand cash...$2,727K Canceled cashflow$8,228K Payments of long-termdebt$4,308K Payments on notes payable$1,202K Payments of deferredoffering costs$130K Payments of penaltiesfrom long-term debt$28K Contract liabilities$1,701K Debt related chargesincluded in interest...$1,586K Accrued excise taxes andfees$1,305K Amortization anddepreciation$912K Equity-based compensation$421K Provision for creditlosses$388K Impairment of long-livedassets - held for sale$293K Amortization of right-of-useassets$245K Change in fair value ofwarrant liabilities$207K Impairment of long-livedassets$150K Deferred income taxes$7K Proceeds from the sale ofproperty, plant and...$770K Payments received from2025 gvb promissory...$100K Net cash used inoperating activities-$7,723K Net cash used ininvesting activities-$505K Canceled cashflow$7,215K Canceled cashflow$870K Net loss-$5,054K Accounts payable-$2,656K Inventories$2,050K Acquisition of patents,trademarks, and licenses$814K Accounts receivable$1,883K Other liabilities-$1,387K Prepaid expenses andother assets$1,350K Change in inventoryreserves-$261K Accrued expenses andother current...-$253K Other non-cash gains$32K (gain) loss on sale ordisposal of property,...$12K Issuance of 2025 gvbpromissory note$500K Acquisition of property,plant and equipment$61K

22nd Century Group, Inc. (XXII)

22nd Century Group, Inc. (XXII)